COMP vs SYRE
Comparison between Compass Inc - Class A (COMP, Company) and Spyre Therapeutics Inc (SYRE, Company).
COMP is from the Real Estate sector, while SYRE is from the Healthcare sector.
5-Year PerformanceCOMP has outperformed SYRE, delivering a return of -10.0% compared to -13.3%
COMP vs SYRE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
COMP vs SYRE - Historical Returns
Returns include dividend reinvestment.
COMP vs SYRE - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | COMP | SYRE |
|---|---|---|
| 2026 | -18.14% | +164.19% |
| 2025 | +82.24% | +37.36% |
| 2024 | +65.25% | +8.79% |
| 2023 | +69.37% | +104.27% |
| 2022 | -75.60% | -90.57% |
| 2021 | -54.89% | -44.51% |
| 2020 | N/A | +1.55% |
| 2019 | N/A | -4.98% |
| 2018 | N/A | +39.22% |
| 2017 | N/A | +18.38% |
| 2016 | N/A | -55.48% |
COMP vs SYRE Drawdown Comparison
The maximum drawdown for COMP was -90.82%, occurring on Nov 9, 2022. This drawdown has not yet recovered.
The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.
The current COMP drawdown is -57.34%. The current SYRE drawdown is -73.05%.
| Rank | COMP | SYRE |
|---|---|---|
| #1 | -90.82% Apr 1, 2021 - Nov 9, 2022 | -99.11% Apr 8, 2016 - Jun 21, 2023 |
Correlation
Correlation between COMP and SYRE is 0.80 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks